HeartBeam (NASDAQ:BEATW – Get Free Report) is expected to be issuing its results after the market closes on Thursday, November 5th. Analysts expect HeartBeam to announce earnings of ($0.09) per share and revenue of $0.07 million for the quarter.
HeartBeam Price Performance
NASDAQ:BEATW opened at $0.01 on Tuesday. HeartBeam has a twelve month low of $0.00 and a twelve month high of $0.56. The company’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.07.
About HeartBeam
HeartBeam, Inc is a medical technology company developing portable, patient-directed cardiac monitoring solutions. The company’s platform is designed to capture and transmit electrocardiogram (ECG) data outside traditional clinical settings, supporting the evaluation of symptoms such as palpitations and irregular heart rhythms.
HeartBeam’s principal product is the AIMIGo system, a compact, cable-free device intended to record a three-dimensional, 12-lead-equivalent ECG. The system works with a smartphone application and related software to help users collect cardiac data and share it with healthcare professionals for review.
Recommended Stories
- Five stocks we like better than HeartBeam
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
Receive News & Ratings for HeartBeam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HeartBeam and related companies with MarketBeat.com's FREE daily email newsletter.
